Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric J Downer

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Molecules (Basel, Switzerland)|March 26, 2022
Botanically-Derived Δ<sup>9</sup>-Tetrahydrocannabinol and Cannabidiol, and Their 1:1 Combination, Modulate Toll-like Receptor 3 and 4 Signalling in Immune Cells from People with Multiple SclerosisJohn-Mark Fitzpatrick, Becky Hackett, Lisa Costelloe, et al.
Biochemical Pharmacology|March 4, 2024
Toll-like receptor signalling as a cannabinoid targetMelody Cui Sun, Almudena Otálora-Alcaraz, Jack A Prenderville, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|December 2, 2017
Plasma IL-8 signature correlates with pain and depressive symptomatology in patients with burning mouth syndrome: Results from a pilot studyAlison Barry, Ken D O'Halloran, Joseph P McKenna, et al.
The Journal of Biological Chemistry|January 24, 2016
The synthetic cannabinoid R(+)WIN55,212-2 augments interferon-β expression via peroxisome proliferator-activated receptor-αEric J Downer, Eileen Clifford, Sylvie Amu, et al.
The Journal of Biological Chemistry|June 2, 2012
The synthetic cannabinoid R(+)WIN55,212-2 augments interferon-β expression via peroxisome proliferator-activated receptor-αEric J Downer, Eileen Clifford, Sylvie Amu, et al.
Journal of Neuroinflammation|May 31, 2012
Dok2 mediates the CD200Fc attenuation of Aβ-induced changes in gliaAnthony Lyons, Eric J Downer, Derek A Costello, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 25, 2016
Delineating the Role of Toll-Like Receptors in the Neuro-inflammation Model EAEFrancesca Fallarino, Marco Gargaro, Giada Mondanell, et al.
Neuronal Signaling|September 9, 2021
Cannabidiol modulation of oxidative stress and signallingSónia R Pereira, Becky Hackett, David N O'Driscoll, et al.
Journal of Neuroimmunology|April 4, 2020
MyD88-dependent and -independent signalling via TLR3 and TLR4 are differentially modulated by Δ<sup>9</sup>-tetrahydrocannabinol and cannabidiol in human macrophagesJohn-Mark Fitzpatrick, Eleanor Minogue, Lucy Curham, et al.
The Journal of Biological Chemistry|January 20, 2011
Identification of the synthetic cannabinoid R(+)WIN55,212-2 as a novel regulator of IFN regulatory factor 3 activation and IFN-beta expression: relevance to therapeutic effects in models of multiple sclerosisEric J Downer, Eileen Clifford, Bruno Gran, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Molecules (Basel, Switzerland)|March 26, 2022
Botanically-Derived Δ<sup>9</sup>-Tetrahydrocannabinol and Cannabidiol, and Their 1:1 Combination, Modulate Toll-like Receptor 3 and 4 Signalling in Immune Cells from People with Multiple SclerosisJohn-Mark Fitzpatrick, Becky Hackett, Lisa Costelloe, et al.
Biochemical Pharmacology|March 4, 2024
Toll-like receptor signalling as a cannabinoid targetMelody Cui Sun, Almudena Otálora-Alcaraz, Jack A Prenderville, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|December 2, 2017
Plasma IL-8 signature correlates with pain and depressive symptomatology in patients with burning mouth syndrome: Results from a pilot studyAlison Barry, Ken D O'Halloran, Joseph P McKenna, et al.
The Journal of Biological Chemistry|January 24, 2016
The synthetic cannabinoid R(+)WIN55,212-2 augments interferon-β expression via peroxisome proliferator-activated receptor-αEric J Downer, Eileen Clifford, Sylvie Amu, et al.
The Journal of Biological Chemistry|June 2, 2012
The synthetic cannabinoid R(+)WIN55,212-2 augments interferon-β expression via peroxisome proliferator-activated receptor-αEric J Downer, Eileen Clifford, Sylvie Amu, et al.
Journal of Neuroinflammation|May 31, 2012
Dok2 mediates the CD200Fc attenuation of Aβ-induced changes in gliaAnthony Lyons, Eric J Downer, Derek A Costello, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 25, 2016
Delineating the Role of Toll-Like Receptors in the Neuro-inflammation Model EAEFrancesca Fallarino, Marco Gargaro, Giada Mondanell, et al.
Neuronal Signaling|September 9, 2021
Cannabidiol modulation of oxidative stress and signallingSónia R Pereira, Becky Hackett, David N O'Driscoll, et al.
Journal of Neuroimmunology|April 4, 2020
MyD88-dependent and -independent signalling via TLR3 and TLR4 are differentially modulated by Δ<sup>9</sup>-tetrahydrocannabinol and cannabidiol in human macrophagesJohn-Mark Fitzpatrick, Eleanor Minogue, Lucy Curham, et al.
The Journal of Biological Chemistry|January 20, 2011
Identification of the synthetic cannabinoid R(+)WIN55,212-2 as a novel regulator of IFN regulatory factor 3 activation and IFN-beta expression: relevance to therapeutic effects in models of multiple sclerosisEric J Downer, Eileen Clifford, Bruno Gran, et al.
Pageof 5